Stockscreener 앱 받기
3.68
3.66%
-0.14
전일 마감가:
$3.82
열려 있는:
$3.75
하루 거래량:
68,103
Relative Volume:
0.48
시가총액:
$40.28M
수익:
-
순이익/손실:
$-19.25M
주가수익비율:
-2.0674
EPS:
-1.78
순현금흐름:
$-17.87M
1주 성능:
-7.54%
1개월 성능:
-10.46%
6개월 성능:
+3.95%
1년 성능:
+12.20%
1일 변동 폭
$3.64
$3.905
1주일 범위
$3.64
$4.09
52주 변동 폭
$2.55
$6.118
Lantern Pharma Inc Stock (LTRN) Company Profile
명칭
Lantern Pharma Inc
전화
972-277-1136
주소
1920 MCKINNEY AVENUE, DALLAS, TX
LTRN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LTRN
Lantern Pharma Inc
|
3.73 | 41.25M | 0 | -19.25M | -17.87M | -1.78 |
|
VRTX
Vertex Pharmaceuticals Inc
|
428.55 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
631.32 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
426.50 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
841.11 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
184.03 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Lantern Pharma Inc Stock (LTRN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-10-07 | 개시 | H.C. Wainwright | Buy |
Lantern Pharma Inc 주식(LTRN)의 최신 뉴스
Will Lantern Pharma Inc. stock recover after recent dropTrade Risk Summary & Technical Pattern Alert System - newser.com
Can Lantern Pharma Inc. stock deliver consistent earnings growth2025 Earnings Impact & Daily Volume Surge Trade Alerts - newser.com
How Lantern Pharma Inc. stock reacts to oil pricesTrade Volume Summary & Risk Controlled Stock Pick Alerts - newser.com
Why Lantern Pharma Inc. stock is favored by pension fundsGap Up & High Accuracy Investment Entry Signals - newser.com
Will Lantern Pharma Inc. stock maintain dividend yieldQuarterly Trade Review & Breakout Confirmation Trade Signals - newser.com
Lantern Pharma : Corporate Overview - MarketScreener
How Lantern Pharma Inc. stock performs in weak economyQuarterly Profit Review & Low Risk High Win Rate Stock Picks - newser.com
Is Lantern Pharma Inc. stock a buy before product launchesCEO Change & Accurate Intraday Trade Tips - newser.com
When is the best time to exit Lantern Pharma Inc.2025 Market Trends & Technical Confirmation Trade Alerts - newser.com
What drives Lantern Pharma Inc stock priceEvening Star Patterns & Big Gains Small Budget - earlytimes.in
Is Lantern Pharma Inc. stock attractive for income investorsQuarterly Profit Summary & Short-Term Trading Alerts - newser.com
Using economic indicators to assess Lantern Pharma Inc. potentialJuly 2025 Institutional & Safe Investment Capital Preservation Plans - newser.com
Enlivex Therapeutics and Lantern Pharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Pocono Record
Full technical analysis of Lantern Pharma Inc. stock2025 Valuation Update & Weekly Breakout Watchlists - newser.com
Lantern Pharma Inc. stock trendline breakdownTrade Volume Summary & Advanced Technical Analysis Signals - newser.com
How to interpret RSI for Lantern Pharma Inc. stockJuly 2025 Momentum & Reliable Intraday Trade Plans - newser.com
Lantern Pharma to Present AI-Driven Cancer Drug Development & Research Platforms at Inaugural AI for Biology and Medicine Symposium at UNT - MarketScreener
Emerging Biotech Stars Poised for Multi-Billion-Dollar Breakthroughs (MDCX, ACTU, LTRN, TNXP) - MarketScreener
Lantern Pharma Presents LP-284 Clinical Data at 25th LL&M Congress, Highlighting Complete Response in Therapeutically Exhausted DLBCL Patient & Therapeutic Potential in Advanced B-Cell Cancers. - BioSpace
Lantern Pharma (NASDAQ: LTRN) Reports Complete Metabolic Response in Phase 1 LP-284 Trial at LL&M Congress - Digital Journal
Lantern Pharma (LTRN) Reports Promising Phase 1 Trial Results fo - GuruFocus
Lantern Pharma presents LP-284 clinical data at 25th LL&M Congress - MarketScreener
What technical signals suggest for Lantern Pharma Inc. stockGDP Growth & Growth Focused Stock Pick Reports - fcp.pa.gov.br
Lantern Pharma’s Promising Phase II Lung Cancer Study: Key Insights for Investors - TipRanks
Lantern Pharma’s LP-284 Study: A Potential Game-Changer in Cancer Treatment? - TipRanks
Lantern Pharma Inc (LTRN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Lantern Pharma Inc 주식 (LTRN) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Kreis Leslie W. | 10% Owner |
Jun 13 '25 |
Sale |
3.09 |
40,000 |
123,600 |
49,957 |
| Fletcher Aaron G.L. | 10% Owner |
Jun 12 '25 |
Sale |
3.38 |
60,647 |
204,987 |
51,860 |
| Fletcher Aaron G.L. | 10% Owner |
Jun 11 '25 |
Sale |
3.40 |
950 |
3,230 |
54,746 |
| Fletcher Aaron G.L. | 10% Owner |
Jun 10 '25 |
Sale |
3.40 |
16 |
54 |
54,791 |
| Kreis Leslie W. | 10% Owner |
Jun 12 '25 |
Sale |
3.38 |
60,647 |
204,987 |
51,860 |
| Kreis Leslie W. | 10% Owner |
Jun 11 '25 |
Sale |
3.40 |
950 |
3,230 |
54,746 |
| Kreis Leslie W. | 10% Owner |
Jun 10 '25 |
Sale |
3.40 |
16 |
54 |
54,791 |
| Fletcher Aaron G.L. | 10% Owner |
May 27 '25 |
Sale |
3.05 |
21,037 |
64,163 |
56,467 |
| Fletcher Aaron G.L. | 10% Owner |
May 29 '25 |
Sale |
3.03 |
20,200 |
61,206 |
54,792 |
| Fletcher Aaron G.L. | 10% Owner |
May 28 '25 |
Sale |
2.87 |
15,000 |
43,050 |
55,753 |
1.35%
0.35%
자본화:
|
볼륨(24시간):